- Silgan reported record Q3 adjusted EPS at the high end of its prior guidance range.
- Full-year earnings estimate midpoint raised following strong dispensing performance in pharma and fragrance.
- Announced acquisition of Trivium to accelerate portfolio transformation.
?? Positive AI Sentiment (+4.5 / 10)